Harbour BioMed's partner Spruce Biosciences separates CRHX-101 into Adrenyx Biosciences
US FDA clears Medtronic plc's Hugo robotic-assisted surgery system for general surgery
Sobi's Tryngolza for severe hypertriglyceridaemia receives EU approval
Apotex launches generic version of INLYTA in US market
Genentech secures first FDA approval for primary membranous nephropathy treatment
ViiV Healthcare receives positive EU recommendation for expanded paediatric HIV treatments
Rezolute's ersodetug meets primary endpoint in Phase 3 upLIFT study of tumour hyperinsulinism
Sunnyside adds GLP-1 options to its medication program for Alcohol Use Disorder